|
Tokyo, Japan-based Arysta LifeScience and Bayer CropScience have announced a package of agreements that further expand their cooperation. Financial terms of the transaction were not disclosed. Under the agreement, Arysta will acquire from Bayer a broad spectrum acaricide and selective insecticide called amitraz, sold under the tradename Mitac. The company also will be granted an exclusive license for marketing Bayer's fluoxastrobin for crop uses in the US, Canada and Japan as well as an exclusive license for marketing the compound globally for non-crop uses such as on turf and ornamentals. Bayer will supply Arysta with fluoxastrobin for sale in these markets as well as with tebuconazole for in-can mixtures with fluoxastrobin in the US. Arysta LifeScience also will be granted a co-exclusive license to co-market deltamethrin, a pyrethroid insecticide, in the US crop protection market.
"These products will enhance our portfolio in specialty crops - including fruits, vegetables and vines - especially in North America and Japan, and worldwide in the turf and ornamental sector," says Chris Richards, president and CEO of Arysta LifeScience. Arysta's focus in crop protection is specialty crops, including fruits and vines, and niche and emerging markets. |
||||||||||
